Singapore, Singapore

R Manjunatha Kini

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Singapore, IN (2000)
  • Singapore, SG (1999 - 2022)

Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: R Manjunatha Kini: Innovator in Retinal Treatment and Thrombin Inhibition

Introduction

R Manjunatha Kini is a prominent inventor based in Singapore, known for his significant contributions to the fields of medical science and biotechnology. With a total of 15 patents to his name, he has made remarkable advancements in the treatment of retinal diseases and thrombin inhibition.

Latest Patents

Among his latest patents is Angio-3, which focuses on the treatment of retinal angiogenic diseases. This innovative disclosure outlines methods for treating retinal angiogenic conditions in subjects by administering an effective amount of an Angio-3 peptide. Another notable invention is related to thrombin inhibitors, where he provides isolated peptides, variants, and fragments that can bind with high specificity to thrombin, effectively inhibiting its activity. This invention also includes potential applications in diagnosis, treatment, coating of medical devices, and nucleic acids encoding the same.

Career Highlights

R Manjunatha Kini has had a distinguished career, working with esteemed institutions such as Virginia Commonwealth University and the National University of Singapore. His work has significantly impacted the medical field, particularly in developing therapeutic solutions for complex health issues.

Collaborations

He has collaborated with notable professionals in his field, including Herbert J Evans and Cho Yeow Koh, further enhancing the scope and impact of his research.

Conclusion

R Manjunatha Kini's innovative work in retinal treatment and thrombin inhibition showcases his dedication to advancing medical science. His contributions continue to pave the way for new therapeutic approaches and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…